BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 4, 2010
View Archived Issues
Cornerstone and Alitair collaborate on drug development for respiratory diseases
Read More
Ajinomoto claims new inhibitors of IL-12/IL-23 production
Read More
ArQule discloses new FGFR inhibitors
Read More
Taisho discovers new DP2 receptor antagonists
Read More
Japanese researchers describe new KIF11 inhibitors
Read More
IGFBP-7 mediates oncogene-induced senescence in papillary thyroid carcinoma
Read More
DAB2IP gene SNP correlates with susceptibility to abdominal aortic aneurism
Read More
Regadenoson SPECT is safe and tolerated in patients with CKD and ESRD
Read More
TBR-652 exhibits potent anti-HIV activity in phase II trial
Read More
Nanobin encapsulation improves therapeutic efficacy of As2O3 in solid tumors
Read More
Lexicon reacquires rights to several serotonin synthesis inhibitors from Symphony Icon
Read More
Merck & Co. identifies new gamma-secretase modulators
Read More
Mallinckrodt claims novel diagnostic agents for renal disorders
Read More
FDA clears first-in-human trial of N-6022
Read More
Seattle Genetics and Genentech expand antibody-drug conjugate agreement
Read More
Diamyd receives upfront payment from OMJP under Diamyd collaboration
Read More
Oxygen signs CRADA with U.S. navy to study decompression sickness therapy
Read More
FusoGen presents phase IIb data on sifuvirtide in HIV
Read More
Pharmachem Laboratories offers to acquire all assets from Forbes Medi-Tech
Read More
First patient receives treatment in phase Ib expansion trial of CUDC-101
Read More
Patient enrollment advances ahead of schedule in phase III Probuphine trial
Read More
Northwest reports phase I/II data on DCVax-Brain personalized immune therapy
Read More
MiddleBrook Pharmaceuticals completes sale of assets to Victory Pharma
Read More
Mitsubishi Tanabe transfers Kerlong marketing rights to sanofi-aventis
Read More
Taisho Pharma discontinues development of TS-022 for atopic dermatitis with pruritus
Read More